Patients who start to take Febuxostat treatment should be rechecked every 2 weeks or so for uric acid, if the long-term control of blood uric acid concentration is satisfactory, then it can be changed to every 3 months to half a year for rechecking. Febuxostat is a kind of drug that can reduce the blood uric acid level of patients by inhibiting the production of uric acid, and is mainly used for the long-term treatment of hyperuricemia in patients with gout. Since the dosage of febuxostat should be adjusted according to the level of blood uric acid in time and the treatment plan, the patients should have their blood uric acid level rechecked every 2 weeks at the beginning of the treatment of febuxostat. Patients should also actively cooperate with dietary management, lifestyle modification and other daily management to further control the uric acid. If patients can control the blood uric acid level within the target range for a long period of time in the later stage, the uric acid level can be changed to be rechecked every 3 months to half a year, in addition to the regular rechecking of routine blood tests and liver and kidney functions for patients taking Febuxostat. Febuxostat should be used under the guidance of a physician, and it is recommended that patients go to the rheumatology and immunology departments of regular hospitals and other related departments for detailed consultation.